文献速递主动脉疾病血液透析通路

基于胶原的血管闭合装置在血管内主动脉瘤修复中的意大利多中心经验:与缝合介导闭合装置的比较

Collagen-Based Vascular Closure Device Multicenter Italian Experience in Endovascular Aortic Aneurysm Repair Compared With Suture-Mediated Closure Vascular Device.
PubMed 文献 · J Endovasc Ther · 2024-09-17

这项回顾性多中心病例对照研究纳入2021年1月至2023年4月意大利各血管外科分校行(胸)血管内主动脉瘤修复的524例经皮股动脉入路,比较Manta与ProGlide两种闭合装置。Manta组鞘管尺寸显著大于ProGlide组(17.2±2.7 Fr vs 15.7±2.3 Fr,p<0.001),但两组在穿刺点并发症及30天结局方面无统计学显著差异。

要点

  • Manta组鞘管尺寸大于ProGlide组(17.2±2.7 Fr vs 15.7±2.3 Fr,p<0.001)。
  • Manta组穿刺点成功闭合率90.5%,ProGlide组93.1%。
  • 两组因任何并发症免于再干预率分别为95.5%(Manta)和96%(ProGlide)。

核心结论

  • 两种血管闭合装置在并发症方面相似,无统计学显著差异,尽管Manta组(胸)血管内主动脉瘤修复所用鞘管中位尺寸显著大于ProGlide组。

研究设计与样本

  • 回顾性多中心病例对照研究,纳入2021年1月至2023年4月意大利各血管外科分校行(胸)血管内主动脉瘤修复的524例连续经皮股动脉入路,其中Manta组355例、ProGlide组169例,采用STROBE标准报告。

主要发现

  • Manta组鞘管尺寸17.2±2.7 Fr,ProGlide组15.7±2.3 Fr(p<0.001)。
  • 两组在年龄、性别、体质指数、超声引导穿刺、股动脉钙化、术中及30天并发症方面无统计学显著差异。
  • Manta组穿刺点成功闭合率90.5%,ProGlide组93.1%。
  • Manta组因任何并发症免于再干预率95.5%,ProGlide组96%。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The Manta Vascular Closure Device is a novel collagen-based vascular closure device that has been designed specifically for closure of large-bore percutaneous arterial accesses. The aim of this retrospective study is to evaluate the immediate and 30-day outcome of Manta at the completion of endovascular aneurysm repair (EVAR) or thoracic endovascular aortic repair (TEVAR). The hypothesis is that Manta is not inferior in obtaining hemostasis compared with the Perclose ProGlide Suture-Mediated Closure System device. MATERIALS AND METHODS: We recruited all the percutaneous accesses for (T)EVAR performed from January 2021 to April 2023 by all the Italian Divisions of Vascular Surgery using Manta at the time of data collection (May 2023). The primary outcome is to evaluate the incidence of complications at the puncture site after Manta implantation and at 1 month, and compare this with ProGlide. We applied the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) criteria for observational studies. RESULTS: Overall, 524 consecutive femoral accesses for (T)EVAR procedures were collected: 355 in the Manta cohort and 169 in the ProGlide cohort, respectively. The size of the sheath was 17.2±2.7 Fr for Manta, 15.7±2.3 Fr for ProGlide (p<0.001). No statistically significant differences between the groups regarding age, sex, body mass index, ultrasound-guided access, femoral calcifications, intraoperative, and 30-day complications. Successful arterial closure at groin puncture sites for (T)EVAR using Manta is 90.5% and 93.1% using ProGlide. Freedom for any reintervention for any complication is 95.5% for Manta and 96% for ProGlide. CONCLUSION: The 2 vascular closure devices have proved to be similar in terms of complications, without any statistically significant difference, although the median size of the sheaths for (T)EVAR was statistically significantly larger when Manta has been used, compared with ProGlide.Clinical ImpactManta® is effective in the hemostasis of the access sites following the completion of (T)EVAR in this multicenter, retrospective, case-control study on 524 percutaneous femoral accesses. Compared to the more popular Proglide®, the average size of the introducers in the Manta® group was significantly larger than in the Proglide® group.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Panagrosso M, Cavallo E, Bracale UM, et al. Collagen-Based Vascular Closure Device Multicenter Italian Experience in Endovascular Aortic Aneurysm Repair Compared With Suture-Mediated Closure Vascular Device. J Endovasc Ther. 2024. PMID: 39287104. doi:10.1177/15266028241275804

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。